Dechra raises £60m for acquisition
Dechra Pharmaceuticals, a £310m market capitalisation veterinary drugs firm, announced plans to raise £60m from a rights issue to help pay for a €135m acquisition. Investec Bank is underwriting the three-for-10 offer.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts